ACM
Altium Capital Management Portfolio holdings
AUM
$34.4M
This Quarter Return
-0.07%
1 Year Return
-2.5%
3 Year Return
+357.21%
5 Year Return
–
10 Year Return
–
AUM
$375M
AUM Growth
+$375M
(-13%)
Cap. Flow
-$44.2M
Cap. Flow
% of AUM
-11.78%
Top 10 Holdings %
Top 10 Hldgs %
22.52%
Holding
176
New
38
Increased
28
Reduced
15
Closed
52
Top Buys
| 1 |
Keros Therapeutics
KROS
|
$4.99M |
| 2 |
Celldex Therapeutics
CLDX
|
$4.96M |
| 3 |
X4 Pharmaceuticals
XFOR
|
$4.26M |
| 4 |
AFMD
Affimed
AFMD
|
$4.11M |
| 5 |
BCYC
Bicycle Therapeutics
BCYC
|
$3.83M |
Top Sells
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$9.33M |
| 2 |
Palisade Bio
PALI
|
$7.43M |
| 3 |
Crinetics Pharmaceuticals
CRNX
|
$7.16M |
| 4 |
ESSA Pharma
EPIX
|
$6.1M |
| 5 |
electroCore
ECOR
|
$5.95M |
Sector Composition
| 1 | Healthcare | 83.78% |
| 2 | Financials | 5.42% |
| 3 | Technology | 2.08% |
| 4 | Industrials | 1.49% |
| 5 | Communication Services | 1.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
POL.WS
1
DELISTED
Polished.com Inc. Warrants to Purchase Common Stock
POL.WS
| $11.6M | 3.03% | 6,886,600 | – | – |
|
|
BLU
2
DELISTED
BELLUS Health Inc.
BLU
| $11M | 2.88% | 1,788,789 | – | – |
|
|
3
Celldex Therapeutics
CLDX
$1.47B
| $9.99M | 2.62% | 185,000 +91,884 | +99% | +$4.96M |
|
|
CTIC
4
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $9.77M | 2.56% | 3,313,000 -365,677 | -10% | -$1.08M |
|
5
Aldeyra Therapeutics
ALDX
$351M
| $7.59M | 1.99% | 864,020 | – | – |
|
6
Lantheus
LNTH
$3.73B
| $7.45M | 1.95% | 290,000 +49,934 | +21% | +$1.28M |
|
7
Xtant Medical Holdings
XTNT
$83.3M
| $6.94M | 1.82% | 6,254,458 -2,038,144 | -25% | -$2.26M |
|
8
Verastem
VSTM
$569M
| $6.94M | 1.82% | 2,253,000 +537,411 | +31% | +$1.66M |
|
9
Cerus
CERS
$251M
| $6.7M | 1.76% | 1,100,000 +285,672 | +35% | +$1.74M |
|
10
Curis
CRIS
$20.9M
| $6.49M | 1.7% | 829,000 | – | – |
|
11
CytomX Therapeutics
CTMX
$336M
| $6.28M | 1.65% | 1,233,642 +371,225 | +43% | +$1.89M |
|
12
Immatics
IMTX
$619M
| $6.23M | 1.63% | 478,987 +134,429 | +39% | +$1.75M |
|
13
Protagonist Therapeutics
PTGX
$3.67B
| $6.13M | 1.61% | 346,000 +63,555 | +23% | +$1.13M |
|
14
Arcutis Biotherapeutics
ARQT
$1.86B
| $6.09M | 1.6% | 255,000 +23,686 | +10% | +$566K |
|
15
Inspire Medical Systems
INSP
$2.77B
| $6.06M | 1.59% | 26,000 +5,345 | +26% | +$1.24M |
|
|
NVRO
16
DELISTED
NEVRO CORP.
NVRO
| $5.94M | 1.56% | 51,000 +24,100 | +90% | +$2.8M |
|
|
KDNY
17
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $5.93M | 1.56% | 465,000 +48,433 | +12% | +$618K |
|
18
CareDx
CDNA
$727M
| $5.7M | 1.5% | 90,000 +26,566 | +42% | +$1.68M |
|
|
SYRS
19
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $5.69M | 1.49% | 1,272,412 +195,470 | +18% | +$874K |
|
20
Insmed
INSM
$28.8B
| $5.6M | 1.47% | 203,354 | – | – |
|
21
Ocular Therapeutix
OCUL
$2.12B
| $5.56M | 1.46% | 556,000 +299,848 | +117% | +$3M |
|
22
Avidity Biosciences
RNA
$5.99B
| $5.54M | 1.45% | 225,000 +36,400 | +19% | +$897K |
|
|
KLR
23
DELISTED
Kaleyra, Inc.
KLR
| $5.34M | 1.4% | 484,592 -155,408 | -24% | -$1.71M |
|
|
ISEE
24
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $5.33M | 1.4% | 328,101 -574,532 | -64% | -$9.33M |
|
25
Haemonetics
HAE
$2.63B
| $5.22M | 1.37% | 74,000 +21,000 | +40% | +$1.48M |
|